MONTREAL, QUEBEC--(MARKET WIRE)--Jun 13, 2007 -- IBEX Technologies Inc. (Toronto:IBT.TO - News), an innovator in the development of research-use diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the three and nine-month periods ended April 30, 2007.